Calidi Biotherapeutics, Inc. Shareholders' Equity
Calidi Biotherapeutics, Inc. (CLDI) had Shareholders' Equity of $3.13 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $3.13M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $4.93M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $3.76M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.92M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $3.13M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.93M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.76M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $6.92M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.76M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $6.94M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.53M 10-K · filed 2026-03-27 | |
| 2024-06-30 | -$11.75M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$14.57M 10-Q · filed 2024-08-13 | |
| 2023-12-31 | -$8.23M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.09M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$63.71M 10-Q · filed 2024-08-13 | -$11.97M 10-Q · filed 2023-08-21 |
| 2023-03-31 | -$55.10M 10-Q · filed 2024-08-13 | -$7.88M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$50.44M 10-Q · filed 2024-08-13 | -$5.21M 10-K · filed 2023-03-31 |
| 2022-09-30 | -$43.93M 10-Q · filed 2023-11-14 | -$9.90M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$39.64M 10-Q · filed 2023-11-14 | -$9.24M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$37.62M 10-Q · filed 2023-11-14 | -$13.24M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$31.61M 10-K · filed 2024-03-15 | -$14.69M 10-K · filed 2022-03-31 |
| 2021-09-30 | -$18.98M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$58.30K 10-Q · filed 2022-11-14 | |
| 2021-04-30 | $15.00K 10-Q · filed 2021-11-12 | |
| 2021-03-31 | $25.00K 10-Q · filed 2022-11-14 | |
| 2021-03-23 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |